Bright Minds Biosciences Inc. ( DRUG) - Key Metrics
DRUG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.11 | -$0.99 | -$0.99 |
| 2026Q1 | $0 | -$0.97 | -$0.75 | -$0.75 |
| 2025Q4 | $0 | -$0.57 | -$0.18 | -$0.18 |
| 2025Q3 | $0 | -$0.74 | -$0.49 | -$0.49 |
| 2025Q2 | $0 | -$0.66 | -$0.54 | -$0.54 |
DRUG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -22.66 |
| 2026Q1 | 0% | -27.60 |
| 2025Q4 | 0% | -51.48 |
| 2025Q3 | 0% | -12.00 |
| 2025Q2 | 0% | -19.66 |
DRUG
Price: $84.04
52 week price:
Earnings Per Share: -2.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 141500
Market Capitalization: 750.0 million